These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 14238600)

  • 1. [ON THE THERAPY OF DIABETES MELLITUS WITH 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN). EXPERIENCES WITH 160 DIABETICS].
    ROBBERS H; BRUMBY KH; TRAUMANN KJ
    Arzneimittelforschung; 1964 May; 14():406-9. PubMed ID: 14238600
    [No Abstract]   [Full Text] [Related]  

  • 2. [ORAL THERAPY OF DIABETES MELLITUS WITH 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN)].
    BERNHARD H
    Arzneimittelforschung; 1964 May; 14():411-2. PubMed ID: 14238602
    [No Abstract]   [Full Text] [Related]  

  • 3. [REPORT ON THE CLINICAL TESTING OF 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW ORAL ANTIDIABETIC].
    LEUBNER H
    Arzneimittelforschung; 1964 May; 14():404-6. PubMed ID: 14238599
    [No Abstract]   [Full Text] [Related]  

  • 4. [2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW ORAL ANTIDIABETIC].
    GUTSCHE H; BOENICKE G
    Arzneimittelforschung; 1964 May; 14():409-11. PubMed ID: 14238601
    [No Abstract]   [Full Text] [Related]  

  • 5. [TOLERANCE OF 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN) IN LONG-TERM ADMINISTRATION IN ANIMAL EXPERIMENTS].
    KRAMER M; HECHT G; GUENZEL P; HARWART A; RICHTER KD; GLOXHUBER C
    Arzneimittelforschung; 1964 May; 14():389-94. PubMed ID: 14238596
    [No Abstract]   [Full Text] [Related]  

  • 6. [2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW BLOOD SUGAR-LOWERING AGENT. I. THE METABOLISM OF GLYCODIAZIN IN MAN].
    GERHARDS E; GIBIAN H; KOLB KH
    Arzneimittelforschung; 1964 May; 14():394-402. PubMed ID: 14238597
    [No Abstract]   [Full Text] [Related]  

  • 7. [PHARMACOLOGY OF 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN), A NEW BLOOD SUGAR-LOWERING COMPOUND].
    KRAMER M; HECHT G; LANGECKER H; HARWART A; RICHTER KD; GLOXHUBER C
    Arzneimittelforschung; 1964 May; 14():377-85. PubMed ID: 14238594
    [No Abstract]   [Full Text] [Related]  

  • 8. [THE BEHAVIOR OF LIVER GLYCOGEN IN DIABETES IN AGED SUBJECTS UNDER THE INFLUENCE OF INSULIN AND THE ORAL ANTIDIABETIC 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PY RIMIDINE (GLYCODIAZIN)].
    BERINGER A; THALER H
    Arzneimittelforschung; 1964 May; 14():403-4. PubMed ID: 14238598
    [No Abstract]   [Full Text] [Related]  

  • 9. [RESORPTION, DISTRIBUTION AND EXCRETION OF RADIOACTIVE-LABELLED 2-BENZENESULFONAMIDO-5-(2-METHOXYETHOXY)-PYRIMIDINE (GLYCODIAZIN) IN ANIMAL EXPERIMENTS].
    KOLB KH; KRAMER M; SCHULZE PE
    Arzneimittelforschung; 1964 May; 14():385-9. PubMed ID: 14238595
    [No Abstract]   [Full Text] [Related]  

  • 10. LONG-TERM OBSERVATIONS ON ORAL HYPOGLYCEMIC AGENTS IN DIABETES; THE EFFECT OF CARBUTAMIDE AND TOLBUTAMIDE.
    BERNHARD H
    Diabetes; 1965 Feb; 14():59-70. PubMed ID: 14256053
    [No Abstract]   [Full Text] [Related]  

  • 11. [2 CASES OF HEMIPLEGIA INDICATIVE OF SEVERE HYPOGLYCEMIA INDUCED BY HYPOGLYCEMIC SULFONAMIDES].
    HAZARD J; DOMART A
    Bull Mem Soc Med Hop Paris; 1965 Feb; 116():473-6. PubMed ID: 14308218
    [No Abstract]   [Full Text] [Related]  

  • 12. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
    GRINNELL EH; SKILLMAN TG; BARSE R; MOLLER CL
    Curr Ther Res Clin Exp; 1964 Jul; 6():433-41. PubMed ID: 14203273
    [No Abstract]   [Full Text] [Related]  

  • 13. GLYCODIAZINE IN DIABETES MELLITUS: A CLINICAL TRIAL.
    STEWART RD; ANDERSON DE
    Br Med J; 1965 Sep; 2(5463):682-4. PubMed ID: 14337736
    [No Abstract]   [Full Text] [Related]  

  • 14. [CLINICAL EXPERIENCES WITH A NEW ORAL HYPOGLYCEMIC DRUG, ACETOHEXAMIDE].
    CHANIS RA
    Arch Med Panamenos; 1963 Dec; 12():193-206. PubMed ID: 14161953
    [No Abstract]   [Full Text] [Related]  

  • 15. [OUR EXPERIENCES WITH ORAL ANTIDIABETICS IN OUTPATIENT CONTROL AND TREATMENT OF DIABETIC PATIENTS].
    ANGELI I
    Orv Hetil; 1964 Nov; 105():2186-90. PubMed ID: 14216805
    [No Abstract]   [Full Text] [Related]  

  • 16. ORAL MEDICATION IN DIABETES.
    SCHUSTER F
    J Am Inst Homeopath; 1964; 57():241-6. PubMed ID: 14216362
    [No Abstract]   [Full Text] [Related]  

  • 17. ACETOHEXAMIDE ('DIMELOR') IN DIABETES.
    HERMAN M; JACKSON WP
    S Afr Med J; 1964 Jul; 38():519-22. PubMed ID: 14182168
    [No Abstract]   [Full Text] [Related]  

  • 18. ORAL HYPOGLYCEMIC DRUGS: COMPARATIVE EVALUATION OF TOLBUTAMIDE, CHLORPROPAMIDE AND PHENFORMIN.
    MOSS JM; DELAWTER DE; GALLAGHER EJ
    Med Times; 1964 Jul; 92():645-54. PubMed ID: 14184191
    [No Abstract]   [Full Text] [Related]  

  • 19. [CLINICAL TRIALS OF A BIGUANIDE-TOLBUTAMIDE COMBINATION].
    TEITELBAUM M; MILLER G; VAGUE J
    Diabete; 1965 Jan; 13():25-31. PubMed ID: 14284496
    [No Abstract]   [Full Text] [Related]  

  • 20. [SEVERE HYPOGLYCEMIA IN DIABETICS TREATED WITH HYPOGLYCEMIC SULFONAMIDES (APROPOS OF 3 CASES)].
    LAROCHE C; NENNA A; CREMER G; CAQUET R
    Bull Mem Soc Med Hop Paris; 1965 Feb; 116():461-6. PubMed ID: 14308216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.